Pharmaceutical Industry Blog

Last Updated: July 14, 2026 TL;DR: Myanmar — a nation of more than 54 million people whose health system runs from national and regional public hospitals to a fast-growing private sector, and which imports the large majority of its finished pharmaceuticals and almost all of its active pharmaceutical ingredients — depends on a reliable, compliant supply of sterile injectables. Every imported sterile injectable must hold a registration certificate issued by the Food and Drug Ad

Last Updated: July 14, 2026 TL;DR: Kenya — a nation of more than 57 million people, the commercial and pharmaceutical hub of East Africa and the trade gateway for its landlocked neighbours through the port of Mombasa and the Northern Corridor — depends on a reliable, compliant supply of sterile injectables and imports the majority of its finished injectables and almost all of its active pharmaceutical ingredients. Every imported sterile injectable must hold a registration (ma

Last Updated: July 12, 2026 TL;DR: South Africa — a nation of more than 60 million people with the most industrialised economy and one of the most developed health systems in Africa, split between a large public sector and a substantial private sector funded by medical schemes — depends on a reliable, compliant supply of sterile injectables and imports a significant share of its finished injectables and the majority of its active pharmaceutical ingredients. Every sterile inje

Last Updated: July 12, 2026 TL;DR: Tanzania — a nation of more than 65 million people with a health system anchored by public hospitals and the Medical Stores Department (MSD), a fast-growing private sector, and a role as the trade gateway for several landlocked East African neighbours — depends on a reliable, compliant supply of sterile injectables and imports the large majority of its finished injectables and almost all of its active pharmaceutical ingredients. Every import

Last Updated: July 12, 2026 TL;DR: Thailand — a nation of more than 72 million people with one of Southeast Asia's most developed health systems and universal health coverage delivered through three schemes — depends on a reliable, compliant supply of sterile injectables for its hospitals, its social-insurance programmes and its public procurement, and it imports a large share of its finished injectables and the overwhelming majority of its active pharmaceutical ingredients.

Last Updated: July 12, 2026 TL;DR: Turkey — a nation of more than 86 million people bridging Europe and Asia, with one of the strongest domestic pharmaceutical industries in the region and an assertive localisation (yerlileştirme) policy — produces most of its medicines locally, yet still imports a significant share of specialised sterile injectables, oncology and biotechnology products and a large proportion of its active pharmaceutical ingredients. Every imported sterile in